Met Life Investment Management, LLC Karyopharm Therapeutics Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

58 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$0.72 - $1.66 $43,596 - $100,514
60,551 New
60,551 $91,000
Q3 2023

May 09, 2024
BUY
$1.14 - $1.81 $21,605 - $34,303
18,952 Added 45.91%
60,235 $80,000
Q2 2023

Apr 29, 2024
BUY
$1.79 - $4.59 $107,820 - $276,478
60,235 New
60,235 $107,000
Q2 2023

Aug 10, 2023
BUY
$1.79 - $4.59 $33,924 - $86,989
18,952 Added 45.91%
60,235 $107,000
Q1 2023

May 09, 2024
BUY
$2.84 - $3.92 $117,243 - $161,829
41,283 New
41,283 $161 Million
Q1 2023

May 15, 2023
BUY
$2.84 - $3.92 $33,764 - $46,604
11,889 Added 40.45%
41,283 $160,000
Q4 2022

May 10, 2024
SELL
$2.48 - $5.93 $29,797 - $71,248
-12,015 Reduced 29.02%
29,394 $99,000
Q4 2022

Jun 14, 2023
SELL
$2.48 - $5.93 $29,484 - $70,501
-11,889 Reduced 28.8%
29,394 $99,000
Q4 2022

Mar 22, 2023
SELL
$2.48 - $5.93 $29,797 - $71,248
-12,015 Reduced 29.02%
29,394 $99,000
Q4 2022

Feb 15, 2023
SELL
$2.48 - $5.93 $29,797 - $71,248
-12,015 Reduced 29.02%
29,394 $99,000
Q3 2022

May 10, 2024
BUY
$4.08 - $5.82 $74,239 - $105,900
18,196 Added 78.39%
41,409 $226,000
Q3 2022

Jun 14, 2023
BUY
$4.08 - $5.82 $514 - $733
126 Added 0.31%
41,409 $226,000
Q3 2022

Mar 22, 2023
BUY
$4.08 - $5.82 $74,239 - $105,900
18,196 Added 78.39%
41,409 $226,000
Q3 2022

Nov 14, 2022
BUY
$4.08 - $5.82 $74,239 - $105,900
18,196 Added 78.39%
41,409 $226,000
Q2 2022

May 10, 2024
SELL
$4.15 - $8.37 $77,019 - $155,338
-18,559 Reduced 44.43%
23,213 $104,000
Q2 2022

Jun 20, 2023
SELL
$4.15 - $8.37 $74,990 - $151,245
-18,070 Reduced 43.77%
23,213 $104,000
Q2 2022

Mar 22, 2023
SELL
$4.15 - $8.37 $77,019 - $155,338
-18,559 Reduced 44.43%
23,213 $104,000
Q2 2022

Aug 11, 2022
SELL
$4.15 - $8.37 $77,019 - $155,338
-18,559 Reduced 44.43%
23,213 $105,000
Q1 2022

May 10, 2024
BUY
$5.91 - $14.38 $246,872 - $600,681
41,772 New
41,772 $307,000
Q1 2022

Jun 20, 2023
BUY
$5.91 - $14.38 $2,889 - $7,031
489 Added 1.18%
41,772 $307,000
Q1 2022

Mar 22, 2023
BUY
$5.91 - $14.38 $87,261 - $212,320
14,765 Added 54.67%
41,772 $307,000
Q1 2022

May 12, 2022
BUY
$5.91 - $14.38 $87,261 - $212,320
14,765 Added 54.67%
41,772 $308,000
Q4 2021

May 17, 2024
BUY
$5.21 - $8.61 $90,924 - $150,261
17,452 Added 182.65%
27,007 $173,000
Q4 2021

Jun 21, 2023
SELL
$5.21 - $8.61 $74,377 - $122,916
-14,276 Reduced 34.58%
27,007 $173,000
Q4 2021

Mar 22, 2023
BUY
$5.21 - $8.61 $90,924 - $150,261
17,452 Added 182.65%
27,007 $173,000
Q4 2021

Feb 15, 2022
BUY
$5.21 - $8.61 $90,924 - $150,261
17,452 Added 182.65%
27,007 $174,000
Q3 2021

May 17, 2024
SELL
$4.45 - $10.63 $63,003 - $150,499
-14,158 Reduced 59.71%
9,555 $55,000
Q3 2021

Jun 21, 2023
SELL
$4.45 - $10.63 $141,189 - $337,268
-31,728 Reduced 76.85%
9,555 $55,000
Q3 2021

Mar 22, 2023
SELL
$4.45 - $10.63 $63,003 - $150,499
-14,158 Reduced 59.71%
9,555 $55,000
Q3 2021

Nov 15, 2021
SELL
$4.45 - $10.63 $63,003 - $150,499
-14,158 Reduced 59.71%
9,555 $56,000
Q2 2021

Jun 21, 2023
SELL
$8.11 - $11.11 $142,492 - $195,202
-17,570 Reduced 42.56%
23,713 $244,000
Q1 2021

May 17, 2024
SELL
$9.85 - $17.69 $362,854 - $651,664
-36,838 Reduced 60.84%
23,713 $249,000
Q1 2021

Jun 26, 2023
SELL
$9.85 - $17.69 $173,064 - $310,813
-17,570 Reduced 42.56%
23,713 $249 Million
Q1 2021

Mar 22, 2023
SELL
$9.85 - $17.69 $76,534 - $137,451
-7,770 Reduced 24.68%
23,713 $249,000
Q1 2021

May 14, 2021
SELL
$9.85 - $17.69 $76,534 - $137,451
-7,770 Reduced 24.68%
23,713 $249,000
Q4 2020

Jun 22, 2023
SELL
$14.15 - $17.19 $138,670 - $168,462
-9,800 Reduced 23.74%
31,483 $487,000
Q3 2020

Jun 26, 2023
SELL
$14.14 - $19.71 $138,572 - $193,158
-9,800 Reduced 23.74%
31,483 $459,000
Q2 2020

May 24, 2024
SELL
$16.6 - $25.25 $482,528 - $733,967
-29,068 Reduced 48.01%
31,483 $596 Million
Q2 2020

Jun 26, 2023
SELL
$16.6 - $25.25 $162,680 - $247,450
-9,800 Reduced 23.74%
31,483 $596,000
Q2 2020

Mar 22, 2023
BUY
$16.6 - $25.25 $95,300 - $144,960
5,741 Added 22.3%
31,483 $596,000
Q2 2020

Aug 14, 2020
BUY
$16.6 - $25.25 $95,300 - $144,960
5,741 Added 22.3%
31,483 $596,000
Q1 2020

Jul 12, 2023
SELL
$14.38 - $27.72 $223,479 - $430,796
-15,541 Reduced 37.65%
25,742 $494,000
Q1 2020

Mar 22, 2023
SELL
$14.38 - $27.72 $53,551 - $103,229
-3,724 Reduced 12.64%
25,742 $494,000
Q1 2020

May 15, 2020
SELL
$14.38 - $27.72 $53,551 - $103,229
-3,724 Reduced 12.64%
25,742 $495,000
Q4 2019

Jul 12, 2023
SELL
$9.23 - $19.67 $109,070 - $232,440
-11,817 Reduced 28.62%
29,466 $564,000
Q3 2019

Jul 12, 2023
SELL
$5.66 - $11.85 $66,884 - $140,031
-11,817 Reduced 28.62%
29,466 $283,000
Q3 2019

Mar 22, 2023
BUY
$5.66 - $11.85 $36,331 - $76,065
6,419 Added 27.85%
29,466 $283,000
Q3 2019

Nov 14, 2019
BUY
$5.66 - $11.85 $166,777 - $349,172
29,466 New
29,466 $283,000
Q2 2019

Jul 12, 2023
SELL
$4.32 - $6.43 $51,049 - $75,983
-11,817 Reduced 28.62%
29,466 $176 Million
Q1 2019

May 15, 2019
SELL
$4.12 - $10.25 $94,953 - $236,231
-23,047 Closed
0 $0
Q4 2018

Jul 13, 2023
SELL
$8.2 - $16.95 $149,535 - $309,100
-18,236 Reduced 44.17%
23,047 $215,000
Q4 2018

Mar 22, 2023
SELL
$8.2 - $16.95 $104,230 - $215,451
-12,711 Reduced 35.55%
23,047 $215,000
Q4 2018

Feb 14, 2019
SELL
$8.2 - $16.95 $104,230 - $215,451
-12,711 Reduced 35.55%
23,047 $216,000
Q3 2018

Jul 13, 2023
SELL
$17.03 - $21.18 $310,559 - $386,238
-18,236 Reduced 44.17%
23,047 $392,000
Q3 2018

Mar 22, 2023
BUY
$17.03 - $21.18 $108,378 - $134,789
6,364 Added 21.65%
35,758 $608,000
Q3 2018

Nov 14, 2018
BUY
$17.03 - $21.18 $216,468 - $269,218
12,711 Added 55.15%
35,758 $609,000
Q2 2018

Aug 15, 2018
BUY
$12.0 - $19.88 $93,516 - $154,924
7,793 Added 51.09%
23,047 $392,000
Q4 2017

Feb 15, 2018
BUY
$9.15 - $11.99 $139,574 - $182,895
15,254
15,254 $146,000

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email